---
pmid: '36662884'
title: A multimorphic mutation in IRF4 causes human autosomal dominant combined immunodeficiency.
authors:
- IRF4 International Consortium
- Fornes O
- Jia A
- Kuehn HS
- Min Q
- Pannicke U
- Schleussner N
- Thouenon R
- Yu Z
- de Los Angeles Astbury M
- Biggs CM
- Galicchio M
- Garcia-Campos JA
- Gismondi S
- Gonzalez Villarreal G
- Hildebrand KJ
- Hönig M
- Hou J
- Moshous D
- Pittaluga S
- Qian X
- Rozmus J
- Schulz AS
- Staines-Boone AT
- Sun B
- Sun J
- Uwe S
- Venegas-Montoya E
- Wang W
- Wang X
- Ying W
- Zhai X
- Zhou Q
- Akalin A
- André I
- Barth TFE
- Baumann B
- Brüstle A
- Burgio G
- Bustamante JC
- Casanova JL
- Casarotto MG
- Cavazzana M
- Chentout L
- Cockburn IA
- Costanza M
- Cui C
- Daumke O
- Del Bel KL
- Eibel H
- Feng X
- Franke V
- Gebhardt JCM
- Götz A
- Grunwald S
- Hoareau B
- Hughes TR
- Jacobsen EM
- Janz M
- Jolma A
- Lagresle-Peyrou C
- Lai N
- Li Y
- Lin S
- Lu HY
- Lugo-Reyes SO
- Meng X
- Möller P
- Moreno-Corona N
- Niemela JE
- Novakovsky G
- Perez-Caraballo JJ
- Picard C
- Poggi L
- Puig-Lombardi ME
- Randall KL
- Reisser A
- Schmitt Y
- Seneviratne S
- Sharma M
- Stoddard J
- Sundararaj S
- Sutton H
- Tran LQ
- Wang Y
- Wasserman WW
- Wen Z
- Winkler W
- Xiong E
- Yang AWH
- Yu M
- Zhang L
- Zhang H
- Zhao Q
- Zhen X
- Enders A
- Kracker S
- Martinez-Barricarte R
- Mathas S
- Rosenzweig SD
- Schwarz K
- Turvey SE
- Wang JY
journal: Sci Immunol
year: '2023'
full_text_available: false
pmcid: PMC10825898
doi: 10.1126/sciimmunol.ade7953
---

# A multimorphic mutation in IRF4 causes human autosomal dominant combined immunodeficiency.
**Authors:** IRF4 International Consortium, Fornes O, Jia A, Kuehn HS, Min Q, Pannicke U, Schleussner N, Thouenon R, Yu Z, de Los Angeles Astbury M, Biggs CM, Galicchio M, Garcia-Campos JA, Gismondi S, Gonzalez Villarreal G, Hildebrand KJ, Hönig M, Hou J, Moshous D, Pittaluga S, Qian X, Rozmus J, Schulz AS, Staines-Boone AT, Sun B, Sun J, Uwe S, Venegas-Montoya E, Wang W, Wang X, Ying W, Zhai X, Zhou Q, Akalin A, André I, Barth TFE, Baumann B, Brüstle A, Burgio G, Bustamante JC, Casanova JL, Casarotto MG, Cavazzana M, Chentout L, Cockburn IA, Costanza M, Cui C, Daumke O, Del Bel KL, Eibel H, Feng X, Franke V, Gebhardt JCM, Götz A, Grunwald S, Hoareau B, Hughes TR, Jacobsen EM, Janz M, Jolma A, Lagresle-Peyrou C, Lai N, Li Y, Lin S, Lu HY, Lugo-Reyes SO, Meng X, Möller P, Moreno-Corona N, Niemela JE, Novakovsky G, Perez-Caraballo JJ, Picard C, Poggi L, Puig-Lombardi ME, Randall KL, Reisser A, Schmitt Y, Seneviratne S, Sharma M, Stoddard J, Sundararaj S, Sutton H, Tran LQ, Wang Y, Wasserman WW, Wen Z, Winkler W, Xiong E, Yang AWH, Yu M, Zhang L, Zhang H, Zhao Q, Zhen X, Enders A, Kracker S, Martinez-Barricarte R, Mathas S, Rosenzweig SD, Schwarz K, Turvey SE, Wang JY
**Journal:** Sci Immunol (2023)
**DOI:** [10.1126/sciimmunol.ade7953](https://doi.org/10.1126/sciimmunol.ade7953)
**PMC:** [PMC10825898](https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10825898/)

## Abstract

1. Sci Immunol. 2023 Jan 20;8(79):eade7953. doi: 10.1126/sciimmunol.ade7953. Epub
 2023 Jan 20.

A multimorphic mutation in IRF4 causes human autosomal dominant combined 
immunodeficiency.

IRF4 International Consortium(1); Fornes O, Jia A, Kuehn HS, Min Q, Pannicke U, 
Schleussner N, Thouenon R, Yu Z, de Los Angeles Astbury M, Biggs CM, Galicchio 
M, Garcia-Campos JA, Gismondi S, Gonzalez Villarreal G, Hildebrand KJ, Hönig M, 
Hou J, Moshous D, Pittaluga S, Qian X, Rozmus J, Schulz AS, Staines-Boone AT, 
Sun B, Sun J, Uwe S, Venegas-Montoya E, Wang W, Wang X, Ying W, Zhai X, Zhou Q, 
Akalin A, André I, Barth TFE, Baumann B, Brüstle A, Burgio G, Bustamante JC, 
Casanova JL, Casarotto MG, Cavazzana M, Chentout L, Cockburn IA, Costanza M, Cui 
C, Daumke O, Del Bel KL, Eibel H, Feng X, Franke V, Gebhardt JCM, Götz A, 
Grunwald S, Hoareau B, Hughes TR, Jacobsen EM, Janz M, Jolma A, Lagresle-Peyrou 
C, Lai N, Li Y, Lin S, Lu HY, Lugo-Reyes SO, Meng X, Möller P, Moreno-Corona N, 
Niemela JE, Novakovsky G, Perez-Caraballo JJ, Picard C, Poggi L, Puig-Lombardi 
ME, Randall KL, Reisser A, Schmitt Y, Seneviratne S, Sharma M, Stoddard J, 
Sundararaj S, Sutton H, Tran LQ, Wang Y, Wasserman WW, Wen Z, Winkler W, Xiong 
E, Yang AWH, Yu M, Zhang L, Zhang H, Zhao Q, Zhen X, Enders A, Kracker S, 
Martinez-Barricarte R, Mathas S, Rosenzweig SD, Schwarz K, Turvey SE, Wang JY.

Author information:
(1)Consortium members and affiliations are located at the end of this paper. 
Individual contributions are listed in the Acknowledgements.

Interferon regulatory factor 4 (IRF4) is a transcription factor (TF) and key 
regulator of immune cell development and function. We report a recurrent 
heterozygous mutation in IRF4, p.T95R, causing an autosomal dominant combined 
immunodeficiency (CID) in seven patients from six unrelated families. The 
patients exhibited profound susceptibility to opportunistic infections, notably 
Pneumocystis jirovecii, and presented with agammaglobulinemia. Patients' B cells 
showed impaired maturation, decreased immunoglobulin isotype switching, and 
defective plasma cell differentiation, whereas their T cells contained reduced 
TH17 and TFH populations and exhibited decreased cytokine production. A knock-in 
mouse model of heterozygous T95R showed a severe defect in antibody production 
both at the steady state and after immunization with different types of 
antigens, consistent with the CID observed in these patients. The IRF4T95R 
variant maps to the TF's DNA binding domain, alters its canonical DNA binding 
specificities, and results in a simultaneous multimorphic combination of loss, 
gain, and new functions for IRF4. IRF4T95R behaved as a gain-of-function 
hypermorph by binding to DNA with higher affinity than IRF4WT. Despite this 
increased affinity for DNA, the transcriptional activity on IRF4 canonical genes 
was reduced, showcasing a hypomorphic activity of IRF4T95R. Simultaneously, 
IRF4T95R functions as a neomorph by binding to noncanonical DNA sites to alter 
the gene expression profile, including the transcription of genes exclusively 
induced by IRF4T95R but not by IRF4WT. This previously undescribed multimorphic 
IRF4 pathophysiology disrupts normal lymphocyte biology, causing human disease.

DOI: 10.1126/sciimmunol.ade7953
PMCID: PMC10825898
PMID: 36662884 [Indexed for MEDLINE]
